Valvular Heart Disease Treatment
Valvular Heart Disease Treatment
Valve treatment is a set of options rather than a single ladder, and the skill lies less in doing the operation than in choosing the moment and the method. The moment follows one rule: intervene when the patient has symptoms that the valve explains, or when the heart's function begins to change. The method follows the anatomy and the patient — repair where the leaflets allow it, replacement where they do not, and a catheter-based route when open surgery would treat that particular person badly. This page sets out each of those choices and what recovery asks of the patient.
Watching a valve: an active plan, not a postponement
For many patients the first treatment decision is not to operate, and that decision is neither passive nor a refusal to act. Watching a valve means measuring it at a defined interval, managing the load the heart is carrying, and knowing in advance which changes would end the waiting period. Done properly it is a plan with a review date on it.
Medical treatment in valve disease works on three fronts at once: the symptoms, such as breathlessness and fluid retention; the load on the heart, chiefly blood pressure and, where relevant, the rhythm; and protection against the complications valve disease brings — the clot that forms in an enlarged atrium, and infection settling on a damaged valve. None of these treats the valve itself, and saying so plainly is part of informed care rather than a discouragement.
What watching is not. It is not a reason to stop attending, and it is not a promise that nothing will change. The interval between echocardiograms is set by the severity of the lesion and by how the heart is responding, and the schedule itself — what is checked, how often, and by whom — is set out on the prevention and monitoring page. Letting that interval stretch because the patient feels well is the commonest way a good plan is quietly lost.
The timing rule: symptoms, or a heart that is beginning to change
The timing rule in valve disease can be stated in one sentence, and almost everything else on this page follows from it: intervene when the patient has symptoms the valve explains, or when the heart's function begins to change — not when the valve reaches a particular figure on a report.
| Trigger | What it means | What follows |
|---|---|---|
| Symptoms the valve explains | Breathlessness, fatigue, dizziness or fainting on exertion, or chest tightness that cannot reasonably be attributed to something else | The threshold has been crossed: the operation is planned rather than deferred, because delay from here adds risk without adding benefit |
| A change in the ventricle | A pumping function that has fallen, a chamber that has enlarged past the accepted dimensions, or pressures rising behind the valve | Damage has begun. The argument for operating before symptoms appear is that recovery afterwards is more complete |
| A new irregular rhythm | An irregular heartbeat appearing for the first time, particularly with a narrowed mitral valve | The rhythm needs treating in its own right, and it usually moves the valve up the list rather than down it |
| A first event | A fainting episode on exertion, a transient stroke, or an episode of severe breathlessness | The disease has shown what its next episode could be; assessment becomes urgent rather than routine, and treatment is planned during that admission |
Every trigger in that table has the same structure: it marks the point at which the harm of waiting begins to exceed the risk of the procedure. It is also why the same measurement can lead to an operation in one patient and to another year of watching in another. The decision is about what the valve is doing to that person — which is the difference between treating a disease and treating a number.
Repair or replace: the first question after the decision to operate
Once an operation is planned, the first question is whether the valve can be repaired rather than replaced. Repair keeps the patient's own tissue, usually avoids lifelong anticoagulation, preserves the shape and function of the heart better, and is generally the preferred answer whenever the anatomy allows it — which is why so much of the pre-operative imaging is spent describing the leaflets in fine detail.
| Option | What it involves | Where it fits best |
|---|---|---|
| Valve repair | Reshaping, re-supporting or reattaching the patient's own leaflets, often with a ring to stabilise the base of the valve | Preferred for a leaking mitral valve whose anatomy suits it, and for some leaking tricuspid valves; it usually avoids lifelong anticoagulation |
| Valve replacement | Removing the diseased valve and implanting a prosthesis — either during an operation or through a catheter | The standard answer for a narrowed aortic valve, for valves too damaged or infected to repair, and wherever repair is not anatomically possible |
The dividing line is anatomy rather than preference. A leaking mitral valve whose leaflets are too far apart, or too scarred by infection or previous radiation, will not hold after a repair — and a surgeon who repairs it anyway has bought the patient a second operation. A narrowed aortic valve, by contrast, is essentially never repaired: the leaflets have been destroyed by calcification, and replacement is the answer.
The catheter route: TAVI and transcatheter mitral repair
The most important change in valve treatment in recent decades is that not every valve has to be reached through the chest. Catheter-based procedures deliver a valve or a repair device through the arteries or the apex of the heart, and they have widened the group of patients who can be treated at all — the older and frailer patients in particular, whom open surgery would treat badly.
| Procedure | How it works | Who it is considered for |
|---|---|---|
| Transcatheter aortic valve implantation | A new valve is carried on a catheter to the aortic position, usually through an artery in the groin, and expanded inside the diseased valve | Patients with a narrowed aortic valve whose age and other conditions make open surgery a poor option; the choice is made by a heart team rather than by preference |
| Transcatheter edge-to-edge mitral repair | A clip is placed across the two mitral leaflets so that they meet in the middle, reducing the leak without opening the chest | Selected patients with a leaking mitral valve whose leaflet anatomy suits a clip — the imaging that decides this is described on the diagnosis page |
| Catheter balloon treatment | A balloon is inflated across a narrowed valve to open it, without implanting a prosthesis | Selected narrowed mitral valves, and as a bridging measure in some patients before a definitive operation |
A catheter procedure is not simply the easier version of surgery. It is chosen because for one particular patient it offers a better balance of benefit and risk, and the same patient might be better served by an operation. That judgement is made by a team in which interventional cardiologists and cardiac surgeons look at the same images together — the practical meaning of the words heart team.
If the valve is replaced: mechanical or biological
When the valve is replaced rather than repaired, the prosthesis becomes something the patient lives with for years, and the choice comes down to a trade-off that should be stated plainly: durability against anticoagulation.
| Prosthesis | What it is | What it means for the patient |
|---|---|---|
| Mechanical valve | A manufactured valve, usually of pyrolytic carbon, designed to last for decades | Requires lifelong anticoagulation with regular monitoring, and carries a small added risk of clot and bleeding; often favoured in younger patients who can manage the monitoring |
| Biological valve | A valve made from treated animal tissue, or from donated human tissue | Usually avoids lifelong anticoagulation, but the tissue degenerates with time — and the younger the patient, the faster that happens, so it is often favoured in older patients |
Two further points belong here, because they are where patients most often feel the choice was made for them rather than with them. The first is that neither option is a concession: a mechanical valve given to a patient who cannot manage monitoring is a hazard, and a biological valve given to a patient of forty is a reoperation waiting to happen. The second is that the arithmetic is sometimes already settled — a narrowed mitral valve with an irregular rhythm may need anticoagulation for the rhythm itself, whichever prosthesis is chosen.
The choice is shared, and it is revisable in discussion but not afterwards. Ask what the monitoring of anticoagulation involves in your own circumstances, how long the tissue valve being offered is expected to last at your age, and whether a repair is possible after all. Those three questions are the ones that turn a preference into a decision.
Recovery: a schedule with milestones rather than a mood
Recovery from valve treatment follows a schedule rather than a mood, and being able to name its milestones makes the weeks after discharge considerably less frightening for both the patient and the family.
- The first days — after open surgery, a period in intensive care is expected and usually brief; the milestones are breathing comfortably without support, moving, and having pain controlled well enough to cough and breathe deeply.
- The first weeks — if the chest was opened, sternal precautions apply: no lifting and no pushing with the arms. Walking is encouraged and increased daily, and the wound is inspected for infection.
- The medication plan — anticoagulation or antiplatelet treatment settled and written down before discharge, with the monitoring arrangements it requires and a clear instruction for missed doses.
- The follow-up dates — the first review and the first post-treatment echocardiogram are given dates before the patient leaves, and the long-term surveillance interval is stated rather than implied.
- The rehabilitation programme — a supervised programme is what converts an operation into a level of activity; it should be prescribed, not merely suggested.